Inhibrx Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $307.9M
Liabilities Breakdown FY2023
Total Liabilities: $264.4M
Asset Breakdown
Total Assets: $307.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $277.9M | 90.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.4M | 2.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $23.6M | 7.6% |
Liabilities Breakdown
Total Liabilities: $264.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.0M | 4.1% |
| Long-Term Debt | $207.0M | 78.3% |
| Other Liabilities | $46.5M | 17.6% |